TICKVALE
>⌘K
NYSE · CIK 0000310158 · PHARMACEUTICAL PREPARATIONS

Merck & Co., Inc.

MRK chart by TradingView
P/E 100.0xP/B 7.6xP/SALES 4.8xEV/EBITDA FCF YIELD 5.06%

PRICE HISTORY

LIVE · NYSE
MRK chart by TradingView
REVENUE FY2025 ENDED DEC 2025
$65.0B
EBITDA
FREE CASH FLOW
$12.4B
EPS
$7.28
GROSS MARGIN
74.80%
ROIC
20.96%
Q2 FY26ENDED JUN 2026HOVERDRAG ACROSS ANY CHART TO SCRUB ALL 24 · 40 QUARTERS SHOWNVALUATIONGROWTHPROFITABILITY & RETURNSCASH & CAPITALBALANCE SHEET

VALUATION

what you pay for a unit of the business7 CHARTS

P / E RATIO (TTM)

100.0x
+231%
LATEST · Q2 FY26
100.0xQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
11.0x760.5x

P / SALES (TTM)

4.8x
+15%
LATEST · Q2 FY26
4.8xQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
3.1x5.7x

P / BOOK

7.6x
+100%
LATEST · Q2 FY26
7.6xQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
3.8x8.6x

EV / EBITDA (TTM)

LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

EV / REVENUE (TTM)

5.5x
+19%
LATEST · Q2 FY26
5.5xQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
3.6x6.1x

FCF YIELD (TTM)

5.06%
-0.6pp
LATEST · Q2 FY26
5.06%Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
2.26%7.50%

DIVIDEND YIELD (TTM)

2.61%
-0.5pp
LATEST · Q2 FY26
2.61%Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
2.27%4.04%

GROWTH

is the business getting bigger5 CHARTS

REVENUE

$16.6B
+58%
LATEST · Q2 FY26
16.6BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

EBITDA (DERIVED)

LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

NET INCOME

$-1.3B
-161%
LATEST · Q2 FY26
-1.3BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

EPS (DILUTED)

$-0.54
-169%
LATEST · Q2 FY26
-0.54Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

REVENUE GROWTH YOY

5.07%
+0.5pp
LATEST · Q2 FY26
5.07%Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
-62.28%121.29%

PROFITABILITY & RETURNS

what survives to the bottom, and what it earns on capital4 CHARTS

FCF MARGIN

26.96%
+2.6pp
LATEST · Q2 FY26
26.96%Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
-15.61%90.67%

RETURN ON CAPITAL

3.57%
-5.4pp
LATEST · Q2 FY26
3.57%Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
0.56%25.42%

RETURN ON EQUITY (TTM)

7.57%
-5.0pp
LATEST · Q2 FY26
7.57%Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
0.97%39.47%

MARGIN FUNNEL

every line is a share of the same revenue, so they read on one scale — the gaps are what each layer takes out, and net rises above operating when income arrives from outside the business
GROSS MARGIN73.54%
OPERATING MARGIN
NET MARGIN-8.04%
FCF MARGIN26.96%
103.7164.5925.46-13.66-52.78GROSSNETFCFQ3 FY16Q3 FY17Q3 FY18Q3 FY19Q3 FY20Q3 FY21Q3 FY22Q3 FY23Q3 FY24Q3 FY25Q2 FY26

CASH & CAPITAL

where the money actually goes5 CHARTS

FREE CASH FLOW

$4.5B
+75%
LATEST · Q2 FY26
4.5BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

STOCK-BASED COMP

$0.3B
+287%
LATEST · Q2 FY26
0.3BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

CAPITAL EXPENDITURE

$0.9B
+118%
LATEST · Q2 FY26
0.9BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

SHARES OUTSTANDING

2.47B
-11%
LATEST · Q2 FY26
2.47BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

DIVIDEND / SHARE

$0.85
+85%
LATEST · Q2 FY26
0.85Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

BALANCE SHEET

how much cushion there is3 CHARTS

CASH & EQUIVALENTS

$6.8B
-13%
LATEST · Q2 FY26
6.8BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

TOTAL DEBT

$53.9B
+114%
LATEST · Q2 FY26
53.9BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

DEBT / EBITDA (TTM)

LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

OWNERSHIP

10 LARGEST HOLDERS · WHO OWNS THE FLOAT
INSTITUTIONS 82.51%INSIDERS 0.06%OTHER / RETAIL 17.43%4,799 INSTITUTIONAL FILERS
HOLDER% HELDSHARESVALUECHANGE
Blackrock Inc.9.14%225.8M$29.04B+3.1%
Vanguard Capital Management LLC6.52%161.0M$20.70BNEW
State Street Corporation4.83%119.3M$15.34B-0.6%
Wellington Management Group, LLP3.41%84.3M$10.84B-2.5%
Vanguard Portfolio Management LLC2.73%67.3M$8.65BNEW
Geode Capital Management, LLC2.41%59.6M$7.66B-0.8%
JPMORGAN CHASE & CO2.14%53.0M$6.81B+81.4%
Charles Schwab Investment Management, Inc.2.01%49.8M$6.40B+2.5%
Morgan Stanley1.93%47.6M$6.12B+6.0%
FMR, LLC1.80%44.5M$5.72B+9.0%
AS OF 2026-03-31 · MOST RECENT 13F FILINGS
SOURCE → 10-K · 10-Q · 8-K / GUIDANCE · ALL FILINGS
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.